Ignorer les liens de navigation
Qui sommes nous ? Référence-Recherche Pôle Formation Formation universitaire Formation continue E-Formation Formation en partenariat DPC Documentation & publications Service QRE Sang & Transfusion sanguine Europe & International
INTS in English INTS in English
 
 


Votre recherche : [La BTT] AUTEUR égal Snyder E
9 résultat(s)


 
BTT Pietersz RN, Reesink HW, Panzer S, Gilbertson MP, Borosak ME, Wood EM, Leitner GC, Rabitsch W, Ay C, Lambermont M, Deneys V, Sondag D, Compernolle V, Legrand D, Francois A, Tardivel R, Garban F, Sawant RB, Rebulla P, Handa M, Ohto H, Kerkhoffs JL, Brand A, Zhiburt E, Cid J, Escolar G, Lozano M, Puig L, Knutson F, Hallbook H, Lubenow N, Estcourt L, Stanworth S, Murphy MF, Williams L, Mraz DL, Ross RL, Snyder E. Prophylactic platelet transfusions. Vox Sang. 2012;103:159-176.
Thèmes : Produits sanguins plaquettaires ; maj-2012-11
Notice PubMed
BTT Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, Fung M, Hamilton M, Hess JR, Luban N, Perkins JG, Sachais BS, Shander A, Silverman T, Snyder E, Tormey C, Waters J, Djulbegovic B. Evidence-based practice guidelines for plasma transfusion. Transfusion. 2010;50:1227-1239.
Thèmes : Plasma et dérivés plasmatiques ; maj-2010-11
BTT Murphy S, Snyder E, Cable R, Slichter SJ, Strauss RG, McCullough J, Lin JS, Corash L, Conlan MG. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light. Transfusion. 2006;46:24-33.
Thèmes : Produits sanguins plaquettaires ; Inactivation des pathogènes ; maj-2006-03
BTT AuBuchon JP, Herschel L, Roger J, Dumont L, Murphy S, Slichter SJ, Whitley P, Snyder E, Goodrich RP. Comparison of computerized formulae for determination of platelet recovery and survival. Transfusion. 2005;45:1237-1239.
Thèmes : Transfusion homologue ; Produits sanguins plaquettaires ; maj-2005-10
BTT Benjamin RJ, McCullough J, Mintz PD, Snyder E, Spotnitz WD, Rizzo RJ, Wages D, Lin JS, Wood L, Corash L, Conlan MG. Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients. Transfusion. 2005;45:1739-1749.
Thèmes : Inactivation des pathogènes ; maj-2005-12
BTT Hess JR, Kagen LR, van der Meer PF, Simon T, Cardigan R, Greenwalt TJ, AuBuchon JP, Brand A, Lockwood W, Zanella A, Adamson J, Snyder E, Taylor HL, Moroff G, Hogman C. Interlaboratory comparison of red-cell ATP, 2,3-diphosphoglycerate and haemolysis measurements. Vox Sang. 2005;89:44-48.
Thèmes : Techniques d'obtention des produits sanguins ; Produits sanguins érythrocytaires ; maj-2005-10
BTT Snyder E, McCullough J, Slichter SJ, Strauss RG, Lopez-Plaza I, Lin JS, Corash L, Conlan MG. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion. 2005;45:1864-1875.
Thèmes : Produits sanguins plaquettaires ; Inactivation des pathogènes ; maj-2006-03
BTT McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Fridey JL, Raife T, Cable R, Murphy S, Howard F, Davis K, Lin JS, Metzel P, Corash L, Koutsoukos A, Lin L, Buchholz DH, Conlan MG. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood. 2004;104:1534-1541.
Thèmes : Produits sanguins plaquettaires ; Inactivation des pathogènes
BTT Snyder E, Raife T, Lin L, Cimino G, Metzel P, Rheinschmidt M, Baril L, Davis K, Buchholz DH, Corash L, Conlan MG. Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light. Transfusion. 2004;44:1732-1740.
Thèmes : Inactivation des pathogènes ; maj-2005-01